Iguratimod alleviates systemic lupus erythematosus-induced renal injury by inhibiting IL-33/ST2 pathway
Minerva Med
.
2021 Jan 19.
doi: 10.23736/S0026-4806.20.07227-4.
Online ahead of print.
Authors
Nali Hou
1
,
Lipeng Liu
1
,
Xinmei Ma
2
Affiliations
1
Department of Rheumatology and Immunology, Zaozhuang Municipal Hospital, Zaozhuang, China.
2
Department of Rheumatology and Immunology, Zaozhuang Municipal Hospital, Zaozhuang, China - fsmymxm2018@126.com.
PMID:
33464229
DOI:
10.23736/S0026-4806.20.07227-4
No abstract available